Skip to main content

Advertisement

SpringerLink
Log in

Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E et al. Treatment of multiple myeloma. Blood 2004; 103: 20–32.

    Article  CAS  Google Scholar 

  2. Moscow JA . Methotrexate transport and resistance. Leuk Lymphoma 1998; 30: 215–224.

    Article  CAS  Google Scholar 

  3. Robien K, Boynton A, Ulrich CM . Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 2005; 6: 673–689.

    Article  CAS  Google Scholar 

  4. Liu S, Huang H, Lu X, Golinski M, Comesse S, Watt D et al. Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol Cancer Res 2003; 1: 665–673.

    CAS  PubMed  Google Scholar 

  5. Huang Y, Sadee W . Membrane transporters and channels in chemoresistance and sensitivity of tumor cells. Cancer Lett 2006; 239: 168–182.

    Article  CAS  Google Scholar 

  6. Crawford DC, Nickerson DA . Definition and clinical importance of haplotypes. Annu Rev Med 2005; 56: 303–320.

    Article  CAS  Google Scholar 

  7. Kelemen LE . The role of folate receptor alpha in cancer development, progression and treatment: Cause, consequence or innocent bystander? Int J Cancer 2006; 119: 243–250.

    Article  CAS  Google Scholar 

  8. Chiusolo P, Farina G, Putzulu R, Reddiconto G, Fiorini A, De Stefano V et al. Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma. Ann Hematol 2006; 85: 474–477.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Pier Paolo Fattori, MD, Anna Maria Mianulli, MD, and Manuela Imola, MD, for their contribution to patient recruitment. We acknowledge the support of Mrs Alison Frank in revising the English language.

Author information

Author notes

  1. V Maggini and G Buda: These two authors contributed equally to this study.

Authors and Affiliations

  1. Department of Biology, Pisa University, Pisa, Italy

    V Maggini, E Conidi, R Barale & A M Rossi

  2. Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy

    G Buda, S Galimberti & M Petrini

  3. Department of Internal Medicine and Biomedical Science, Hematology and BMT Center, Parma University, Parma, Italy

    N Giuliani & V Rizzoli

  4. Haematology Service – S Annunziata Hospital, Cosenza, Italy

    F Morabito

  5. Department of Oncology, Division of Onco-Hematology, Infermi Hospital, Rimini, Italy

    G Genestreti

  6. Hematology Department, Bone Marrow Transplant Unit, AO Reggio Calabria, Italy

    P Iacopino

Authors
  1. V Maggini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Buda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Galimberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Conidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Giuliani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Morabito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G Genestreti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P Iacopino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V Rizzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R Barale
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Petrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A M Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V Maggini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maggini, V., Buda, G., Galimberti, S. et al. Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation. Leukemia 21, 176–178 (2007). https://doi.org/10.1038/sj.leu.2404455

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404455

  • Springer Nature Limited

This article is cited by

Search

Navigation